PT Bank Oke Indonesia Tbk (DNAR.JK)
IDR 107.0
(-6.09%)
IDR 107.0
(-6.09%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 342.67 Billion | -983.69 Billion | 156.92 Billion | -577.73 Billion | -200.53 Billion | 264.01 Billion |
| Net Income | 28.65 Billion | 13.21 Billion | 17.46 Billion | 7.87 Billion | -16.92 Billion | 19.81 Billion |
| Depreciation & Amortization | 36.84 Billion | 45.72 Billion | 49.33 Billion | 49.05 Billion | 26.53 Billion | 26.69 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -7.04 Billion | 8.38 Billion | 3.39 Billion | 17.7 Billion | 9.23 Billion | -37.86 Billion |
| Other non-cash items | 284.22 Billion | -1051.01 Billion | 86.73 Billion | -652.36 Billion | -219.38 Billion | 244.2 Billion |
| Investing Cash Flow | -1155.15 Billion | -466.83 Billion | -235.81 Billion | -151.99 Billion | 98.02 Billion | -1.67 Billion |
| Investments in PPE | -28.91 Billion | -17.87 Billion | -12.36 Billion | -17.01 Billion | -39.75 Billion | -1.67 Billion |
| Acquisitions | 82.2 Million | 20.1 Million | 6.55 Billion | 4 Million | 793.4 Million | 210.51 Million |
| Investment purchases | -688.41 Billion | -518.6 Billion | -373.9 Billion | -134.98 Billion | -793.4 Million | - |
| Sales/Maturities of investments | 220.41 Billion | 69.63 Billion | 150.45 Billion | 56.58 Billion | 136.98 Billion | 291.46 Billion |
| Other Investing Activities | -658.32 Billion | -463.6 Billion | -6.54 Billion | -56.58 Billion | 793.4 Million | 9.7 Million |
| Financing Cash Flow | 883.15 Billion | 990.34 Billion | 491.52 Billion | 493.57 Billion | 445.31 Billion | -74.04 Billion |
| Debt repayment | -194.18 Billion | -524.41 Billion | -101.39 Billion | -225.64 Billion | -261.03 Billion | -173.41 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -22.58 Billion | -55.2 Billion | - |
| Common Stock Issuance | - | 499.42 Billion | 499.82 Billion | 521.1 Billion | 500.51 Billion | - |
| Other Financing Activities | 1077.33 Billion | 1015.34 Billion | 93.08 Billion | 446.34 Billion | 594.79 Billion | -74.04 Billion |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -7.04 Billion | 8.38 Billion | 3.39 Billion | 17.7 Billion | 9.23 Billion | -1.71 Billion |
| Cash at beginning of period | 962.01 Billion | 1422.17 Billion | 1009.53 Billion | 1245.68 Billion | 902.89 Billion | 569.92 Billion |
| Cash at end of period | 1032.7 Billion | 961.99 Billion | 1422.17 Billion | 1009.53 Billion | 1245.68 Billion | 832.27 Billion |
| Capital Expenditure | -28.91 Billion | -17.87 Billion | -12.36 Billion | -17.01 Billion | -39.75 Billion | -1.67 Billion |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 70.68 Billion | -460.17 Billion | 412.63 Billion | -236.15 Billion | 342.79 Billion | 262.34 Billion |
| Free Cash Flow | 313.76 Billion | -1001.56 Billion | 144.56 Billion | -594.74 Billion | -240.28 Billion | 262.33 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 15.59 Billion | 12.96 Billion | 4.3 Billion | 7.98 Billion | 28.65 Billion | 9.21 Billion |
| Depreciation & Amortization | 8.39 Billion | 9.17 Billion | 9.97 Billion | 10.89 Billion | 36.84 Billion | 8.86 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 20.7 Billion | 14.78 Billion | -17.61 Billion | 15.67 Billion | -7.04 Billion | -13.27 Billion |
| Other non-cash items | 88.65 Billion | 60.82 Billion | 94.82 Billion | 51.49 Billion | 284.22 Billion | 305.19 Billion |
| Investing Cash Flow | 32.83 Billion | -557.31 Billion | 141.51 Billion | 54.1 Billion | -1155.15 Billion | -13.45 Billion |
| Investments in PPE | -133.35 Billion | -79.4 Billion | -850.06 Million | -6.45 Billion | -28.91 Billion | -17.88 Billion |
| Acquisitions | -750.85 Million | -663.91 Million | 2.79 Billion | 10.51 Million | 82.2 Million | 1 Billion |
| Investment purchases | -61.31 Billion | -250.73 Billion | -29.5 Billion | -51.53 Billion | -688.41 Billion | -94.6 Billion |
| Sales/Maturities of investments | 4.93 Billion | 173.7 Billion | 82.46 Billion | 56.02 Billion | 220.41 Billion | 99.04 Billion |
| Other Investing Activities | 90.1 Billion | -11.39 Billion | -1.00 | 56.06 Billion | -658.32 Billion | -1 Billion |
| Financing Cash Flow | -231.44 Billion | 768 Billion | -407.93 Billion | 121.28 Billion | 883.15 Billion | -7.74 Billion |
| Debt repayment | -56.04 Billion | -107.44 Billion | -37.19 Billion | -148.61 Billion | -194.18 Billion | -117.68 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -175.39 Billion | 180.03 Billion | 180.03 Billion | 269.9 Billion | 1077.33 Billion | 109.94 Billion |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 20.7 Billion | -197.91 Billion | -197.91 Billion | 15.67 Billion | -7.04 Billion | -13.27 Billion |
| Cash at beginning of period | - | 837.82 Billion | 1032.7 Billion | 771.24 Billion | 962.01 Billion | 482.44 Billion |
| Cash at end of period | -65.25 Billion | 1127.92 Billion | 837.82 Billion | 1032.7 Billion | 1032.7 Billion | 771.24 Billion |
| Capital Expenditure | -133.35 Billion | -79.4 Billion | -850.06 Million | -6.45 Billion | -28.91 Billion | -17.88 Billion |
| Effect of forex changes on cash | - | - | - | 23.08 Million | - | - |
| Net cash flow / Change in cash | -65.25 Billion | 290.09 Billion | -194.87 Billion | 261.46 Billion | 70.68 Billion | 288.79 Billion |
| Free Cash Flow | - | - | 70.69 Billion | 79.59 Billion | 313.76 Billion | 292.1 Billion |
ACLHF
011230
4439
TCANF
META
2QO